Literature DB >> 12472512

Sudden deafness: long-term follow-up and recurrence.

A Furuhashi1, K Matsuda, K Asahi, T Nakashima.   

Abstract

We examined the long-term outcome for patients with idiopathic sudden sensorineural hearing loss (sudden deafness), including the incidence of recurrence of sudden deafness. The subjects were 1,798 individuals who came to Nagoya University hospital within 2 weeks of the onset of unilateral sudden deafness. Only 14 of the patients had a history of being diagnosed with sudden deafness. After their visit to our hospital, one patient had a recurrence in the ipsilateral ear and four patients experienced sudden deafness in the contralateral ear. We performed hearing examinations on 88 patients who revisited our hospital more than 10 years after unilateral sudden deafness. Of these patients, there was one with a recurrence in the ipsilateral ear and one with sudden deafness in the contralateral ear. Thus, in this series the recurrence of sudden deafness was rare.

Entities:  

Mesh:

Year:  2002        PMID: 12472512     DOI: 10.1046/j.1365-2273.2002.00612.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  22 in total

1.  Sensorineural hearing loss: a complication of acute otitis media in adults.

Authors:  Joo Hyun Park; Sung Joon Park; Young Ho Kim; Min-Hyun Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-30       Impact factor: 2.503

2.  Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Authors:  Christian Mirian; Therese Ovesen
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

3.  Antiphospholipid antibodies in patients with sensorineural hearing loss.

Authors:  Edgar Bachor; Stephan Kremmer; Ernst Kreuzfelder; Klaus Jahnke; Said Seidahmadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-02-25       Impact factor: 2.503

Review 4.  Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.

Authors:  Petros V Vlastarakos; George Papacharalampous; Paul Maragoudakis; George Kampessis; Nicholas Maroudias; Dimitrios Candiloros; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-19       Impact factor: 2.503

5.  Postauricular injection of methylprednisolone sodium succinate as a salvage treatment for refractory sudden sensorineural hearing loss.

Authors:  Gang Ren; Jue Xu; Longjiang Lan; Bingliang Ma; Qi Zhang
Journal:  Ir J Med Sci       Date:  2021-04-17       Impact factor: 1.568

6.  Long-term Audiometric Outcomes in Unilateral Sudden Sensorineural Hearing Loss without Recurrence.

Authors:  Giancarlo Pecorari; Giuseppe Riva; Nertila Naqe; Gabriele Bruno; Matteo Nardo; Roberto Albera
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

7.  Bilateral sudden hearing loss following habitual abortion: a case report and review of literature.

Authors:  Tuanfang Yin; Fengying Huang; Jihao Ren; Wei Liu; Xing Chen; Lihua Li; Dinghua Xie; Yongde Lu
Journal:  Int J Clin Exp Med       Date:  2013-09-01

Review 8.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

9.  Effect of intravenous administration of steroids in the management of sudden sensori-neural hearing loss: our experience.

Authors:  S Raghunandhan; Anoop Kumar Agarwal; Kiran Natarajan; Sathiya Murali; R S Anand Kumar; Mohan Kameswaran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-25

Review 10.  Idiopathic sensorineural hearing disorders in adults--a pragmatic approach.

Authors:  David L George; Sagun Pradhan
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.